drugset / Trial / NCT00960479

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

NCT00960479

Phase 1 Completed 38 enrolled Sandoz
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to demonstrate the relative bioavailability of Ribavirin 200 capsules and Rebetol 200 mg capsules in females under fasting conditions.

Timeline

Start
2001-01
Primary completion
2001-02
Completion
2001-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Ribavirin Small molecule 200 mg Oral